High Altitude, Low Oxygen, Same CGM? Researchers Put Sensor Accuracy to the Test

Continuous glucose monitors have changed diabetes care by giving patients and clinicians glucose information throughout the day. However, what happens when oxygen levels fall? New research examining CGM accuracy during hypoxia raises an important question for people who travel by air, visit high-altitude locations, exercise in low-oxygen environments, or experience medical conditions associated with reduced oxygen levels. A randomized controlled trial known as the FOX Study tested Dexcom G6 and FreeStyle Libre sensors under standardized hypoxic conditions and found that reduced oxygen availability can affect sensor performance.

Table of Contents

• Why oxygen levels may affect CGM readings
• How researchers tested CGM accuracy during hypoxia
• What the FOX Study found
• What the results mean for diabetes care
• Conclusion
• Frequently Asked Questions

Why Oxygen Levels May Affect CGM Sensor Accuracy

Most continuous glucose monitoring systems measure glucose in interstitial fluid rather than directly in the bloodstream. Many sensors use glucose oxidase-based electrochemical reactions to help generate the signal used to estimate glucose levels. Because oxygen can play a role in that process, researchers have questioned whether reduced oxygen availability could influence sensor readings.

Under normal daily conditions, this is usually not a major concern. However, oxygen levels may fall during high-altitude exposure, air travel, strenuous activity at elevation, and certain medical conditions.

The question matters because CGM readings increasingly guide diabetes treatment decisions. Patients may use glucose trends when deciding whether to eat carbohydrates, administer insulin, exercise, or respond to suspected hypoglycemia. In addition, automated insulin delivery systems can use CGM data to adjust insulin delivery with limited user intervention.

Consequently, understanding how hypoxia affects CGM accuracy is more than a technical question. It may have practical implications whenever sensor readings are used to make immediate treatment decisions.

Glucose monitors have become a central part of modern diabetes technology. Therefore, knowing when environmental conditions might affect sensor reliability can help clinicians provide more complete education about their use.

How Researchers Tested CGM Accuracy During Hypoxia

The FOX Study included 30 adults, with 15 healthy volunteers and 15 participants who had diabetes. Among those with diabetes, the group included people with both type 1 and type 2 diabetes.

Participants wore both FreeStyle Libre and Dexcom G6 sensors. Researchers then exposed them to standardized normobaric hypoxia using an inspired oxygen fraction of 14.5%. This approach lowered the amount of oxygen available without changing atmospheric pressure.

Meanwhile, venous plasma glucose measured using a laboratory hexokinase method served as the reference measurement. Participants also consumed a standardized mixed meal and performed moderate-intensity cycling. As a result, researchers were able to observe sensor behavior while glucose levels were changing rather than remaining completely stable.

The primary accuracy measure was mean absolute relative difference, commonly called MARD. In general, a lower MARD indicates closer agreement between CGM readings and reference glucose measurements.

This controlled design gave researchers a useful way to evaluate CGM sensor accuracy under hypoxic conditions while limiting many of the unpredictable variables associated with real-world altitude exposure. However, laboratory hypoxia does not perfectly reproduce every situation a person might encounter during mountain travel or aviation.

That distinction is important because temperature, physical activity, hydration, pressure changes, and rapid glucose fluctuations may also influence real-world sensor performance.

FOX Study Finds Changes in CGM Performance During Hypoxia

The results suggested that both CGM systems experienced some loss of accuracy during hypoxia, although performance differed between the devices and study groups.

Among healthy participants exposed to hypoxia, MARD was 21.2% for FreeStyle Libre and 41.8% for Dexcom G6. Among participants with diabetes, the corresponding values were lower at 11.8% for FreeStyle Libre and 17.5% for Dexcom G6.

Researchers also used consensus error grid analysis to examine whether differences between the sensors and laboratory glucose measurements were likely to have clinical consequences. During hypoxia, 97% of FreeStyle Libre readings and 87% of Dexcom G6 readings fell within zones A or B.

These zones generally represent readings associated with appropriate clinical action or with differences unlikely to produce serious clinical consequences. Nevertheless, the findings showed that low oxygen can influence continuous glucose monitor accuracy under some conditions.

Importantly, inaccuracies appeared more noticeable when glucose levels were changing. That observation matters because rapidly rising or falling glucose already creates challenges when comparing interstitial glucose readings with blood glucose measurements.

Instead of suggesting that CGMs become unusable during low-oxygen exposure, the study indicates that CGM accuracy during hypoxia deserves additional attention. This may be especially relevant when glucose is changing quickly or when an unexpected reading could influence an important treatment decision.

The researchers concluded that selective confirmation with capillary blood glucose testing may be useful when clinically meaningful decisions depend on a sensor reading. The full study is available through PubMed.

What Hypoxia and CGM Accuracy Mean for Diabetes Care

For clinicians, the study reinforces the importance of teaching patients that CGM technology has limits. This is particularly relevant for people planning high-altitude travel, extended activity at elevation, or other situations involving reduced oxygen availability.

Current diabetes technology guidance also supports having access to a blood glucose meter when CGM readings need confirmation. A meter may be especially useful when symptoms do not match the sensor value or when glucose appears to be changing rapidly.

For example, a patient who feels symptoms of hypoglycemia despite a normal CGM reading should not automatically assume the sensor is correct. Instead, confirming the result with a blood glucose measurement may provide additional information when readings appear inconsistent.

This approach does not reduce the value of CGM. Rather, it recognizes that no glucose-monitoring technology is perfect under every physiological or environmental condition.

The issue may become even more important with automated insulin delivery systems because these devices use CGM information to influence insulin dosing. However, the FOX Study was not designed to determine whether hypoxia leads to clinically meaningful changes in automated insulin delivery performance.

More research is therefore needed with newer CGM models, longer periods of altitude exposure, different oxygen levels, and people using automated insulin delivery systems. Future studies may also help determine whether certain sensor technologies are less affected by low oxygen than others.

Ultimately, research on CGM accuracy in low-oxygen conditions provides another reason to individualize diabetes technology education. Patients who expect unusual environmental exposure should discuss monitoring strategies with their diabetes care team or a qualified healthcare professional.

Conclusion

The FOX Study adds useful evidence about CGM performance under reduced oxygen conditions. Both Dexcom G6 and FreeStyle Libre showed changes in accuracy during standardized hypoxia, particularly when glucose levels were changing.

However, the findings do not suggest that people need to stop using CGMs during air travel or altitude exposure. Instead, they highlight the value of understanding sensor limitations and having a backup method available when a reading seems questionable.

Patients should know how their CGM works, pay attention to glucose trends, recognize when symptoms do not match sensor readings, and have access to blood glucose testing when confirmation is appropriate. Meanwhile, the evolving evidence on CGM performance during hypoxia highlights the need for further research involving newer sensors, longer altitude exposure, and automated insulin delivery systems.

Frequently Asked Questions

Does high altitude make a CGM inaccurate?

Reduced oxygen may affect some CGM readings. The FOX Study found changes in sensor accuracy during controlled hypoxia, although the degree of change differed between devices and participants.

Which CGMs were tested in the FOX Study?

Researchers tested Dexcom G6 and FreeStyle Libre sensors. Therefore, the results should not automatically be assumed to apply to every newer CGM model currently available.

Should patients stop using CGM during air travel or high-altitude trips?

The study does not suggest routinely stopping CGM use. Instead, patients should be aware that environmental conditions may affect readings and should have access to a blood glucose meter when confirmation is needed.

Why can CGM readings differ when glucose is changing quickly?

CGMs measure glucose in interstitial fluid rather than directly in blood. As a result, a delay can occur between changes in blood glucose and the values detected by a sensor, especially when glucose is rising or falling rapidly.

Could hypoxia affect automated insulin delivery systems?

It is possible because automated insulin delivery systems rely on CGM data to guide insulin adjustments. However, the FOX Study did not establish how hypoxia affects these systems, so additional research is needed.

This content is not medical advice. For any health issues, always consult a healthcare professional. In an emergency, call 911 or your local emergency services.